Teladoc(US:TDOC) ZACKS·2026-01-08 00:15Company Performance - Teladoc (TDOC) closed at $7.57, reflecting a -5.38% change from the previous day, underperforming the S&P 500 which lost 0.34% [1] - Over the past month, Teladoc shares have increased by 3.9%, while the Medical sector and S&P 500 gained 0.82% and 1.19% respectively [1] Earnings Forecast - The upcoming earnings report for Teladoc is expected to show an EPS of -$0.19, which is a 32.14% improvement from the same quarter last year [2] - Revenue is forecasted at $634.53 million, indicating a 0.93% decline compared to the same quarter last year [2] Full Year Projections - For the full year, earnings are projected at -$1.19 per share and revenue at $2.52 billion, representing a 79.73% increase in earnings and no change in revenue from the previous year [3] - Recent analyst estimate revisions suggest optimism regarding Teladoc's business and profitability [3] Zacks Rank and Industry Position - Teladoc currently holds a Zacks Rank of 4 (Sell), with the Medical Services industry ranked 184, placing it in the bottom 25% of over 250 industries [5] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown that top-rated industries outperform the bottom half by a factor of 2 to 1 [6]